Brief: Lineage Highlights Additional Progress From Clinical Cell Therapy Programs

Lineage Cell Therapeutics

12/08/2021 23:11

Aug 12 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND
HIGHLIGHTS ADDITIONAL PROGRESS FROM CLINICAL CELL THERAPY
PROGRAMS
    * LINEAGE CELL THERAPEUTICS - CASH AND MARKETABLE SECURITIES
OF
$68.7 MILLION EXPECTED TO SUPPORT OPERATIONS WELL INTO 2023
    * LINEAGE CELL THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.03

Source text for Eikon:  ID:nBw8stLGja 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))